Ignite Creation Date:
2025-12-26 @ 12:19 PM
Ignite Modification Date:
2025-12-26 @ 12:19 PM
Study NCT ID:
NCT05577000
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-13
First Post:
2022-10-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma
Sponsor:
Thomas Martin, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-10-18
Start Date Type:
ACTUAL
Primary Completion Date:
2028-10-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2043-10-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-10-08
First Submit QC Date:
None
Study First Post Date:
2022-10-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-07
Last Update Post Date:
2025-08-13
Last Update Post Date Type:
ACTUAL